{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT05931744",
      "orgStudyIdInfo": {
        "id": "MKSU 50-7-8"
      },
      "organization": {
        "fullName": "Kafrelsheikh University",
        "class": "OTHER"
      },
      "briefTitle": "The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis",
      "officialTitle": "The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis . A Randomized Clinical Trial"
    },
    "statusModule": {
      "statusVerifiedDate": "2023-07",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2021-05-01",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2023-02-01",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2023-02-01",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2023-05-12",
      "studyFirstSubmitQcDate": "2023-07-03",
      "studyFirstPostDateStruct": {
        "date": "2023-07-05",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2023-07-03",
      "lastUpdatePostDateStruct": {
        "date": "2023-07-05",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "PRINCIPAL_INVESTIGATOR",
        "investigatorFullName": "Ibrahim M. Gehad",
        "investigatorTitle": "Principal Investigator",
        "investigatorAffiliation": "Kafrelsheikh University"
      },
      "leadSponsor": {
        "name": "Kafrelsheikh University",
        "class": "OTHER"
      }
    },
    "oversightModule": {
      "oversightHasDmc": true,
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "To investigate the usage of budesonide as an agent in the injection of Type 2 chronic rhinosinusitis with nasal polyps",
      "detailedDescription": "this is a randomized controlled clinical trial where 3 groups with nasal polyps will be treated medically, Group A with oral corticosteroids, Group B with budesonide intrapolyp injection, Group C with placebo saline intrapolyp injection"
    },
    "conditionsModule": {
      "conditions": [
        "Chronic Rhinosinusitis With Nasal Polyps"
      ],
      "keywords": [
        "CRSwNP",
        "Intranasal steroid injection",
        "Budesonide"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE2",
        "PHASE3"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "QUADRUPLE",
          "whoMasked": [
            "PARTICIPANT",
            "CARE_PROVIDER",
            "INVESTIGATOR",
            "OUTCOMES_ASSESSOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 120,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Oral steroid",
          "type": "ACTIVE_COMPARATOR",
          "description": "patients given prednisone 1 mg/kg for 3 days then tapered by 5mg daily for two weeks",
          "interventionNames": [
            "Drug: Prednisone"
          ]
        },
        {
          "label": "Budesonide Intrapolyp injection",
          "type": "EXPERIMENTAL",
          "description": "patients given budesonide 0.5 mg/2ml intrapolyp injection once weekly for 5 consecutive weeks",
          "interventionNames": [
            "Drug: Budesonide"
          ]
        },
        {
          "label": "Saline intrapolyp injection",
          "type": "PLACEBO_COMPARATOR",
          "description": "patients given 2ml normal saline intrapolyp injection once weekly for 5 consecutive weeks",
          "interventionNames": [
            "Drug: Saline"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "Budesonide",
          "description": "after application of topical vasoconstrictor packs into both nasal cavities, using 1 cc 28 gauge needle sterile syringe, one pack of budesonide ampule 0.5 mg/2ml was injected into visible polyps on both cavities 1 ml in each cavity weekly for 5 consecutive weeks",
          "armGroupLabels": [
            "Budesonide Intrapolyp injection"
          ]
        },
        {
          "type": "DRUG",
          "name": "Prednisone",
          "description": "patients given oral prednisone 1 mg/ kg with max. dose 70 mg/d divided into two doses for 3 days then tapered gradually for two weeks",
          "armGroupLabels": [
            "Oral steroid"
          ]
        },
        {
          "type": "DRUG",
          "name": "Saline",
          "description": "saline intrapolyp injection",
          "armGroupLabels": [
            "Saline intrapolyp injection"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Sino-Nasal Outcome Test \"SNOT-22\" Score",
          "description": "subjective method to assess the patient's quality of life \"QOL\" and the severity of the disease before and after treatment, The lower the score, The better the condition",
          "timeFrame": "6 months"
        },
        {
          "measure": "CT Lund Mackay",
          "description": "the radiological evaluation of patients with nasal polyps where each sinus was solitarily assigned a score from (0 to 2), where the Osteomeatal Complex was given only (0 or 2), each side was evaluated on its own and the sum of all sinuses was calculated. A combined score of 24 was the maximum. Investigators asked the patients for a CT scan before starting the treatment and 3 months after the completion of each treatment protocol",
          "timeFrame": "6 months"
        },
        {
          "measure": "Total nasal Polyp score \"TNPS\"",
          "description": "the clinical assessment of nasal polyps, the total nasal polyp score \"TNPS\" was used where polyp size was evaluated through endoscopy and given a score from (0 to 3). TNPS was calculated as the sum of the score on each side, and patients were assessed on regular visits before receiving treatment, 1 week after treatment, and after 3 months",
          "timeFrame": "6 months"
        },
        {
          "measure": "Serum IgE",
          "timeFrame": "1 month"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* All patients with type 2 CRSwNP -\n* elevated serum IgE \\& high absolute eosinophilia\n* with any grade of nasal polyps\n* ages between 18 and 60 years old\n* patients who didn't have any contraindications of systemic steroids\n\nExclusion Criteria:\n\n* All patients with previous nasal surgeries\n* All patients with cystic fibrosis, ciliary dyskinesia, antrochoanal polyp, fungal sinusitis, unilateral nasal polyps, nasal tumors,\n* patients who took systemic steroids in the last 6 months before our study\n* patients with any previous nasal surgery",
      "healthyVolunteers": true,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "60 Years",
      "stdAges": [
        "ADULT"
      ]
    },
    "contactsLocationsModule": {
      "locations": [
        {
          "facility": "Kafrelsheikh University hospital",
          "city": "Kafrelsheikh",
          "state": "Kafrelsheikh",
          "zip": "37458",
          "country": "Egypt"
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "YES"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D019819",
          "term": "Budesonide"
        },
        {
          "id": "D011241",
          "term": "Prednisone"
        },
        {
          "id": "D012965",
          "term": "Sodium Chloride"
        }
      ],
      "ancestors": [
        {
          "id": "D011282",
          "term": "Pregnenediones"
        },
        {
          "id": "D011283",
          "term": "Pregnenes"
        },
        {
          "id": "D011278",
          "term": "Pregnanes"
        },
        {
          "id": "D013256",
          "term": "Steroids"
        },
        {
          "id": "D000072473",
          "term": "Fused-Ring Compounds"
        },
        {
          "id": "D011083",
          "term": "Polycyclic Compounds"
        },
        {
          "id": "D011244",
          "term": "Pregnadienediols"
        },
        {
          "id": "D011245",
          "term": "Pregnadienes"
        },
        {
          "id": "D002712",
          "term": "Chlorides"
        },
        {
          "id": "D006851",
          "term": "Hydrochloric Acid"
        },
        {
          "id": "D017606",
          "term": "Chlorine Compounds"
        },
        {
          "id": "D007287",
          "term": "Inorganic Chemicals"
        },
        {
          "id": "D017670",
          "term": "Sodium Compounds"
        }
      ]
    }
  },
  "hasResults": false
}